Dual Cytokine Blocker Keeps Hidden Psoriasis at Bay for Two Full Years
A two-year Japanese real-world study of 66 patients shows the dual IL-17A and IL-17F inhibitor bimekizumab sustained high clearance rates ...
A two-year Japanese real-world study of 66 patients shows the dual IL-17A and IL-17F inhibitor bimekizumab sustained high clearance rates ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine